Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02372266
Other study ID # SGO 96-042
Secondary ID DI950076FWH19960
Status Completed
Phase N/A
First received February 3, 2015
Last updated February 19, 2015
Start date April 1997
Est. completion date August 2001

Study information

Verified date February 2015
Source Wilford Hall Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardUnited States: Federal Government
Study type Interventional

Clinical Trial Summary

To determine the effect of a policy of early maternal-newborn infant discharge (12-24 hours) with a home visit on admission to the Level II/III nursery and hospital admissions and readmissions.


Description:

This is a randomized controlled trial designed to assess the safety of a policy of early maternal newborn infant discharge compared to a policy of routine discharge 2 to 3 days after delivery. The primary outcome is newborn admissions to the Level II or Level III neonatal care unit or hospital within three days of delivery. Secondary outcomes included admissions and readmissions at 2 weeks, 6 weeks and 6 months following delivery, maternal satisfaction with length of stay and overall birthing experience, lactation continuation rates, maternal anxiety, depression, confidence and family functioning. We applied the American Academy of Pediatrics criteria for early newborn discharge, but planned the analysis by intention to treat.


Recruitment information / eligibility

Status Completed
Enrollment 2223
Est. completion date August 2001
Est. primary completion date January 2001
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- All pregnant women enrolling for obstetric care at a large military academic health center

Exclusion Criteria:

- Planning a move from the area before delivery

- Multiple gestations

- Pre-existing maternal diabetes

- Maternal chronic hypertension

- Maternal age < 18

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Early Maternal-Newborn Infant Discharge
Discharge from the hospital between 12-24 hours of life
Routine discharge
Discharge of the mother and newborn 2 to 3 days after delivery

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Wilford Hall Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary Admission to the Level II/III neonatal care unit or hospital All admissions to the Level II/III neonatal care unit following delivery 72 hours Yes
Secondary Emergency department visits, clinic visits, or hospital admissions Any unplanned pediatric visit to an emergency room, clinic or a hospital admission 72 hours Yes
Secondary Emergency department visits, clinic visits, or hospital admissions Any unplanned pediatric visit to an emergency room, clinic or a hospital admission 14 days Yes
Secondary Emergency department visits, clinic visits, or hospital admissions Any unplanned pediatric visit to an emergency room, clinic or a hospital admission 8 weeks No
Secondary Emergency department visits, clinic visits, or hospital admissions Any unplanned pediatric visit to an emergency room, clinic or a hospital admission 6 months No
Secondary Breastfeeding score (5 point Likert scale) 5 point Likert scale: Only breast, mostly breast, 50/50, mostly bottle, only bottle At discharge (12 to 72 hours after delivery) No
Secondary Breastfeeding score (5 point Likert scale) 5 point Likert scale: Only breast, mostly breast, 50/50, mostly bottle, only bottle 14 days No
Secondary Breastfeeding score (5 point Likert scale) 5 point Likert scale: Only breast, mostly breast, 50/50, mostly bottle, only bottle 8 weeks No
Secondary Breastfeeding score (5 point Likert scale) 5 point Likert scale: Only breast, mostly breast, 50/50, mostly bottle, only bottle 6 months No
Secondary Maternal anxiety (State/Trait Anxiety Inventory) At discharge (12 to 72 hours after delivery) No
Secondary Maternal anxiety (State/Trait Anxiety Inventory) State/Trait Anxiety Inventory 14 days No
Secondary Maternal depression (Generalized Contentment Scale) Generalized Contentment Scale At discharge (12 to 72 hours after delivery) No
Secondary Maternal depression (Generalized Contentment Scale) Generalized Contentment Scale 14 days No
Secondary Maternal confidence (Confidence on a Likert scale) Confidence on a Likert scale At discharge (12 to 72 hours after delivery) No
Secondary Maternal confidence (Confidence on a Likert scale) Confidence on a Likert scale 14 days No
Secondary Maternal satisfaction with length of stay (Likert scale) Satisfaction with length of stay on a Likert scale At discharge (12 to 72 hours after delivery) No
Secondary Maternal satisfaction with length of stay (Likert scale) Satisfaction with length of stay on a Likert scale 14 days No
Secondary Maternal satisfaction with overall experience (Likert scale) Satisfaction with overall childbirth experience on a Likert scale At discharge (12 to 72 hours after delivery) No
Secondary Maternal satisfaction with overall experience (Likert scale) Satisfaction with overall childbirth experience on a Likert scale 14 days No
Secondary Admission to the Level II/III neonatal care unit or hospital All admissions to the Level II/III neonatal care unit following delivery 14 days Yes
Secondary Admission to the Level II/III neonatal care unit or hospital All admissions to the Level II/III neonatal care unit following delivery 8 weeks Yes
Secondary Admission to the Level II/III neonatal care unit or hospital All admissions to the Level II/III neonatal care unit following delivery 6 months No
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02528136 - The Clinical Carbetocin Myocardium Trial Phase 4